Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers

Published:2019-05-07 Issue:1 Volume:9 Page:
ISSN:2191-1991
Container-title:Health Economics Review
language:en
Short-container-title:Health Econ Rev

Author:

Berber Arturo^ORCID,Del-Rio-Navarro Blanca Estela

Funder

Hospital Infantil de México Federico Gómez

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s13561-019-0230-1.pdf

Reference23 articles.

1. Ochoa Sangrador C, Barajas Sánchez MV, Muñoz Martín B. Relationship between child day-care attendance and acute infectious disease. A systematic review. Rev Esp Salud Publica. 2007;81:113–29.

2. Flores-Hernandez S, Reyes-Morales H, Perez-Cuevas R, et al. The day care center as a risk factor for acute respiratory infections. Arch Med Res. 1999;30:216–23.

3. Enserink R, Lugnér A, Suijkerbuijk A, et al. Gastrointestinal and respiratory illness in children that do and do not attend child day care centers: a cost-of-illness study. PLoS One 2014;9(8):e104940. doi: https://doi.org/10.1371/journal.pone.0104940 . eCollection 2014.

4. Delpiano L, Kabalán P, Díaz C, et al. Características y costos directos de infecciones respiratorias agudas en niños de guarderías infantiles [acute respiratory infections in children of day care center: characteristics and costs]. Rev Chil Infect. 2006;23(2):128–33.

5. Ahrens J. Multicentre double-blind clinical trial with broncho-vaxom in children. Therapiewoche. 1984;34:3469–75.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children;Cost Effectiveness and Resource Allocation;2023-04-06

2. The Use of Bacterial Lysate for the Prevention of Wheezing Episodes in Preschool Children: A Cost-Utility Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2023-01

3. OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis;BMC Pulmonary Medicine;2022-12-06

4. Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis;BMC Pulmonary Medicine;2022-06-23

5. Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85;Expert Review of Respiratory Medicine;2020-07-15